Qsymia is a combination of two older medications, phentermine and topiramate, and was approved by the FDA for use of chronic weight management in 2012. Similar to Adipex, the phentermine component of Qsymia is believed to trigger the release of norepinephrine in the brain, which increases blood concentrations of the hormone leptin, which is involved in regulating hunger. Topiramate, also known as Topamax, is an anti-seizure and anti-migraine medication that can work along with phentermine to increase a patient’s sense of fullness and make food taste less appealing.
Qsymia is indicated for long-term weight loss use, meaning that a patient can remain on it indefinitely as long as they meet certain weight loss goals. One advantage of this medication is that it comes in 4 strengths, so the dosage can be increased with time if a patient starts to feel less hunger control.
If you’re interested in getting started on Qsymia, or if you have questions about the medication, just fill out an appointment request and one of our Patient Service Representatives will be in touch!
With offices in Ohio, Kentucky, and Indiana JourneyLite is your trusted team for weight loss in the midwest!